Ignite Creation Date:
2024-05-06 @ 7:01 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05863871
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-05-18
First Post:
2023-05-09
Brief Title:
Real World Study of Linperlisib for Lymphoma Treatment
Sponsor:
Ruijin Hospital
Organization:
Ruijin Hospital
Organization Data
Organization:
Ruijin Hospital
Class:
OTHER
Study ID:
E20230190
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ruijin Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Zhao Weili
Responsible Party Title:
MD and PhD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Ruijin Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Tianjin Medical University Cancer Institute and Hospital | OTHER |